Loading clinical trials...
Loading clinical trials...
This study is designed to evaluate the safety and tolerability of Xalacom in patients with primary glaucoma
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT06289491 · Glaucoma, Glaucoma, Open-Angle
NCT05885022 · Glaucoma, Open-Angle
NCT03870230 · Glaucoma, Open-Angle, Normal Tension Glaucoma, and more
NCT06201455 · Glaucoma, Open-Angle, Cataract Complicated, and more
NCT05624398 · Glaucoma, Open-Angle, Cataract
Pfizer Investigational Site
Banovce N. Bebravou
Pfizer Investigational Site
Banská Bystrica
Pfizer Investigational Site
Bojnice
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions